Out-of-pocket costs are not the bottom line in financial toxicity.
Where this comes from
- Record sourced from PubMed, PMID 42559663.
- Also identified by DOI 10.1002/cncr.70561 and PMC identifier 13445136.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Health care–related out‐of‐pocket and indirect costs may create financial barriers to initial and/or continued receipt of care among patients with cancer, and subsequent financial toxicity is associated with worse oncologic and quality of life outcomes. Recognition and mitigation of risk factors for financial toxicity are essential to the provision of equitable, high‐quality care.